Similar Posts
Pesticide firms want to test chemical toxicity on humans instead of rats
Pesticide firms want to test chemical toxicity on humans instead of rats Sat, 4 Jan 2003 Count the reasons why not human pesticide experiments: 1) quantum increase in commodification of subjects, 2) presumptive utter absence of benefit to subjects, 3) end term purpose of inquiry is forensic (e.g. the San…
Examination of Eli Lilly’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance
Peter R. Breggin, M.D. 101 East State Street, No. 112 Ithaca, New York 14850 www.breggin.com Phone: 607 272 5328 Fax: 607 272 5329 January 12, 2005 An Examination of Eli Lilly and Company’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance A report by Peter…
Conflict of Interest
Conflict of Interest: Profits vs Safety Congressional Investigations US Senators Pharmaceutical industry holdings, 2004: http://www.consumerwatchdog.org/resources/SenPharma.pdf Oct 12: How Did the Vioxx Debacle Happen? USA Today / Lancet Oct 4: Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical…
Nazi euthanasia files are made public – BMJ
Nazi euthanasia files are made public – BMJ Fri, 17 Oct 2003 Documents pertaining to Nazi euthanasia–i.e., medically approved murder (1939-1944) have been concealed for half a century by the secret service of the former German Democratic Republic. Among the victims targeted for medical murder were mentally and physically disabled…
Brain Development &Teen Mood Swings – ABC
Brain Development &Teen Mood Swings – ABC Sun, 24 Aug 2003 ABC reports about a brain imaging study using MRI that tracks the brains of normal children. This study provides physical evidence about the biological development of the normal brain and the individual pace of normal development. What’s new, according…
AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme
AstraZeneca Pleads Guilty in Criminal Cancer Medicine Scheme Sun, 22 Jun 2003 AstraZeneca agreed to a $355 million settlement in civil and criminal charges. Government prosecutors found that AstraZeneca reported to the government that the average wholesale price for a monthly dose of the prostate cancer drug, Zoladex, was about…